PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1128762
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1128762
Middle East and Africa anthrax treatment market is projected to register a CAGR of 8.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Middle East and Africa Anthrax Treatment Market, By Type (Cutaneous Anthrax, Pulmonary Anthrax and Intestinal Anthrax), Route of Administration (Oral, Parenteral and Others), End User (Government Organization, Hospitals, Academic and Research Institutes, and Others),Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Rising prevalence of anthrax infections
Increasing research funding and the development of novel therapies for anthrax treatment
Alembic Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Zydus Group
Bayer AG
Pfizer Inc.
Lupin
Teva Pharmaceutical Industries Ltd.
ARISTO Pharmaceuticals Private Limited